# FDA recall D-1413-2014

> **Baxter Healthcare Corp.** · Class II · drug recall initiated 2014-06-16.

## Product

Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.

## Reason for recall

Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1413-2014
- **Recalling firm:** Baxter Healthcare Corp.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-06-16
- **Report date:** 2014-07-09
- **Termination date:** 2017-04-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Deerfield, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1413-2014

## Citation

> AI Analytics. FDA recall D-1413-2014. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1413-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*